Thomas Flaten
Stock Analyst at Lake Street
(4.09)
# 1,565
Out of 4,405 analysts
355
Total ratings
48.6%
Success rate
6.3%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintained: Buy | $60 | $37.64 | +59.40% | 18 | Jun 10, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 → $7 | $1.76 | +297.73% | 8 | May 22, 2026 | |
| AQST Aquestive Therapeutics | Maintained: Buy | $6 | $4.17 | +43.88% | 36 | May 15, 2026 | |
| IMDX Insight Molecular Diagnostics | Maintained: Buy | $12 | $5.61 | +113.90% | 23 | May 14, 2026 | |
| AYTU Aytu BioPharma | Maintained: Buy | $8 → $7 | $2.15 | +225.58% | 6 | May 14, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $9 → $5 | $0.5422 | +822.17% | 14 | May 14, 2026 | |
| DERM Journey Medical | Maintained: Buy | $13 | $6.34 | +105.05% | 15 | May 14, 2026 | |
| ASRT Assertio Holdings | Maintained: Hold | $18 → $24 | $23.48 | +0.09% | 27 | May 13, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $33 | $26.10 | +26.44% | 25 | May 8, 2026 | |
| ARLO Arlo Technologies | Reiterated: Buy | $24 | $12.92 | +85.76% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.64 | +147.25% | 24 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $20.70 | +151.21% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $15.16 | +163.85% | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.03 | +178.33% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $5.52 | +99.28% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $5.65 | +147.79% | 21 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $2.12 | +324.53% | 2 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $27.50 | +81.82% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $9.59 | +14.70% | 27 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $15 | $0.2512 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $2.26 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $47.33 | n/a | 4 | Mar 1, 2022 |
Harrow
Jun 10, 2026
Maintained: Buy
Price Target: $60
Current: $37.64
Upside: +59.40%
Rapid Micro Biosystems
May 22, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $1.76
Upside: +297.73%
Aquestive Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $6
Current: $4.17
Upside: +43.88%
Insight Molecular Diagnostics
May 14, 2026
Maintained: Buy
Price Target: $12
Current: $5.61
Upside: +113.90%
Aytu BioPharma
May 14, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $2.15
Upside: +225.58%
MDxHealth
May 14, 2026
Maintained: Buy
Price Target: $9 → $5
Current: $0.5422
Upside: +822.17%
Journey Medical
May 14, 2026
Maintained: Buy
Price Target: $13
Current: $6.34
Upside: +105.05%
Assertio Holdings
May 13, 2026
Maintained: Hold
Price Target: $18 → $24
Current: $23.48
Upside: +0.09%
BioLife Solutions
May 8, 2026
Maintained: Buy
Price Target: $33
Current: $26.10
Upside: +26.44%
Arlo Technologies
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $12.92
Upside: +85.76%
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $3.64
Upside: +147.25%
May 7, 2026
Maintained: Buy
Price Target: $52
Current: $20.70
Upside: +151.21%
May 5, 2026
Maintained: Buy
Price Target: $40
Current: $15.16
Upside: +163.85%
May 5, 2026
Reiterated: Buy
Price Target: $14
Current: $5.03
Upside: +178.33%
Apr 15, 2026
Maintained: Buy
Price Target: $11
Current: $5.52
Upside: +99.28%
Apr 1, 2026
Maintained: Buy
Price Target: $14
Current: $5.65
Upside: +147.79%
Apr 1, 2026
Maintained: Buy
Price Target: $9
Current: $2.12
Upside: +324.53%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $27.50
Upside: +81.82%
Feb 27, 2026
Maintained: Buy
Price Target: $11
Current: $9.59
Upside: +14.70%
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Maintained: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Maintained: Buy
Price Target: $96 → $15
Current: $0.2512
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: $3.5
Current: $2.26
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $60 → $50
Current: $47.33
Upside: n/a